January Subject To : Enclosu The Bo “Compa resoluti 1. A C 1 1 E 2. A r y 16, 2018 t : Notificat of New D Director an The Stock E ures : 1. Fo A 2. In (a oard of Dire any”) No. 1 ions as follo Acknowledg Committee a 1.1 Ms.Pi 1.2 Mr.Su Effective fro Approved t replace the 2.1 Ms. Comm 2.2 Mr. S tion on the Directors, a nd Manager Exchange o orm for Re Audit Comm nformation M amended No ectors’ meet 1/2018 (the ows, ged the resi as follows: ichitra Mah umate Sang om January the appointm resig...
ที่มีความมั่นคงปลอดภัย [ ข้อ 5.4 แนวปฏิบัติ 3 ทั้งหมด ] คณะทำงานกลุ่มย่อย AIMC ขอเป็น reasonable effort เนื่องจากระบบเก่า หรือระบบใหม่บางระบบ อาจไม่มี feature รองรับหลักเกณฑ์บางประการ สำนักงานได้ปรับ
identified as a holding company or a nominee account, identify the persons or the group of persons who are genuinely the true shareholders and their core businesses unless there is a reasonable ground for
businesses unless there is a reasonable ground for failure of such identification. (2) In case of a holding company, provide information on the shareholders of the subsidiary undertaking the core business
and their core businesses unless there is a reasonable ground for failure of such identification. (2) In case of a holding company, provide information on the shareholders of the subsidiary undertaking
details of the capital increase in the Capital Increase Report Form (F53-4) (Enclosure 3). The Board of Directors has delegated the power to the Senior Accounting and Administration Manager and or any
your information accordingly, Respectfully Yours, (Dr. Ronnachit Mahattanapruet) SVP, Finance and Administration
retirement and medical fee, Information technology and other administration expenses which including sale promotion for Frequent Flyer Program (FFP), Corporate Social Responsibility program (CSR), outsources
retirement, medical fee and bonus, Information technology and other administration expenses which including sale promotion for Frequent Flyer Program (FFP), Corporate Social Responsibility program (CSR
quite a longer process of licenses than expected, e.g., import license and food serial number from the Food and Drug Administration (FDA). In addition, the Company is in the process of adjusting its